- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: American Journal of Respiratory and Critical Care Medicine, 194, 11, S. 1428-1430
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2016
- Ereignis
-
Veröffentlichung
- (wo)
-
New York, NY
- (wer)
-
American Thoracic Society
- (wann)
-
2016
- Urheber
-
Lapa, Constantin Frederik Victor
Grigoleit, Götz Ulrich
Hänscheid, Heribert
Klinker, Erdwine
Jung, Pius
Herrmann, Ken
Schirbel, Andreas
Böck, Markus
Buck, Andreas K.
Pelzer, Theo
- DOI
-
10.1164/rccm.201603-0579le
- URN
-
urn:nbn:de:bvb:384-opus4-630916
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lapa, Constantin Frederik Victor
- Grigoleit, Götz Ulrich
- Hänscheid, Heribert
- Klinker, Erdwine
- Jung, Pius
- Herrmann, Ken
- Schirbel, Andreas
- Böck, Markus
- Buck, Andreas K.
- Pelzer, Theo
- Universität Augsburg
- American Thoracic Society
Entstanden
- 2016
Ähnliche Objekte (12)
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression after myocardial infarction [Letter]
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients
DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities [Abstract]
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression after myocardial infarction [Letter]
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients
DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities [Abstract]
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression after myocardial infarction [Letter]
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients